共 169 条
[1]
Van der Hooft CS(2008)Adverse drug reaction-related hospitalisations: a population-based cohort study Pharmacoepidemiol Drug Saf. 17 365-371
[2]
Dieleman JP(2008)Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands Arch Intern Med. 168 1890-1896
[3]
Siemes C(2000)Nonsteroidal anti-inflammatory drug gastropathy Gastroenterology. 119 521-535
[4]
Aarnoudse A-JLHJ(2000)The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials J Rheumatol. 27 2203-2214
[5]
Verhamme KMC(2012)Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force Drug Saf. 35 245-259
[6]
Stricker BHCH(2013)NHG-Standaard Maagklachten (tweede herziening) [Dutch College of General Practitioners’ (NHG) practice guideline “Gastric symptoms” (second revision)] Huisarts Wet 1 26-35
[7]
Leendertse AJ(2015)Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study Br J Clin Pharmacol. 80 589-598
[8]
Egberts ACG(2006)Long-term proton pump inhibitor therapy and risk of hip fracture JAMA. 296 2947-2953
[9]
Stoker LJ(2006)Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture Calcif Tissue Int. 79 76-83
[10]
van den Bemt PMLA(2008)Use of proton pump inhibitors and risk of osteoporosis-related fractures CMAJ. 179 319-326